EMERYVILLE, Calif., Jan. 4, 2023
/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading
synthetic biotechnology company accelerating the world's transition
to sustainable consumption through its
Lab-to-Market™ technology platform today announced that
management will present at the 41st Annual J.P. Morgan Health Care
Conference on Wednesday, January 11,
2023, at 11:15 am PT
(2:15 pm ET) in San Francisco.
A live webcast of the presentation and a replay will be
available on the Investor Relations section of the company's
website at
https://investors.amyris.com/events-and-presentations.
About Amyris
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology
company, transitioning the Clean Health & Beauty and Flavors
& Fragrances markets to sustainable ingredients through
fermentation and the company's proprietary
Lab-to-Market™ technology platform. This Amyris platform
leverages state-of-the-art machine learning, robotics and
artificial intelligence, enabling the company to rapidly bring new
innovation to market at commercial scale. Amyris ingredients are
included in over 20,000 products from the world's top brands,
reaching more than 300 million consumers. Amyris also owns and
operates a family of consumer brands that is constantly evolving to
meet the growing demand for sustainable, effective and accessible
products. For more information, please visit
http://www.amyris.com.
Amyris, the Amyris logo, and, Lab-to-Market are trademarks or
registered trademarks of Amyris, Inc. or its subsidiaries in the
U.S. and/or other countries.
Investor Contact:
Amyris, Inc.
Paul Vincent
vincent@amyris.com
+1 (510) 450-0761
Argot Partners
Jason Finkelstein
amyris@argotpartners.com
+1 (212) 600-1902
Media Contact:
Amyris, Inc.
Lauren White
lwhite@amyris.com
+1 (202) 320-8677
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amyris-to-present-at-the-41st-annual-jp-morgan-health-care-conference-301712827.html
SOURCE Amyris, Inc.